Beta Wealth Group’s Milestone Pharmaceuticals MIST Stock Holding History

Beta Wealth Group’s Portfolio MIST Stock Details MIST Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$18.9K	Hold	14,127	–	–	0.01%	114
2026 Q1	$16.8K	Hold	14,127	–	–	0.01%	112
2025 Q4	$28.5K	Hold	14,127	–	–	0.01%	115
2025 Q3	$28.3K	Hold	14,127	–	–	0.01%	115
2025 Q2	$27.4K	Hold	14,127	–	–	0.01%	105
2025 Q1	$11.3K	Hold	14,127	–	–	﹤0.01%	105
2024 Q4	$33.3K	Hold	14,127	–	–	0.01%	108
2024 Q3	$21.5K	Hold	14,127	–	–	0.01%	105
2024 Q2	$18.6K	Hold	14,127	–	–	0.01%	103
2024 Q1	$25.3K	Hold	14,127	–	–	0.01%	101
2023 Q4	$23.6K	Hold	14,127	–	–	0.01%	104
2023 Q3	$43.8K	Hold	14,127	–	–	0.03%	97
2023 Q2	$40.3K	Buy	+14,127	New	+$53.3K	0.02%	98
2023 Q1	–	Sell	-14,127	Closed	-$55.9K	–	111
2022 Q4	$55.9K	Buy	+14,127	New	+$74.4K	0.04%	96

Other funds holding MIST

PCM

Pavaki Capital Management Pueblo, Colorado $287M AUM

RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return

PBM

Propel Bio Management Los Angeles, California $191M AUM 102.42% 1-Year Est. Return

Point72 Asset Management Stamford, Connecticut $90.7B AUM 77.13% 1-Year Est. Return

SAM

Simplify Asset Management Las Vegas, Nevada $7.19B AUM 6.88% 1-Year Est. Return

Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return

Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return

KCM

Kalehua Capital Management Dallas, Texas $174M AUM

LPC

Lion Point Capital New York $20.9M AUM 195.52% 1-Year Est. Return

Beta Wealth Group's MIST Position: Q2 2026 in Review

Beta Wealth Group held its Milestone Pharmaceuticals (MIST) position steady in Q2 2026 at 14,127 shares worth $18.9K. The position accounts for 0.01% of the portfolio, ranked #114.

Beta Wealth Group first reported a position in MIST in Q4 2022 and has held it in 14 quarters since. The position peaked at $55.9K in Q4 2022. 78 funds tracked by Wall St. Rank hold MIST as of Q2 2026.

Beta Wealth Group held 14,127 shares of Milestone Pharmaceuticals worth $18.9K as of Q2 2026.
Beta Wealth Group left its Milestone Pharmaceuticals share count unchanged in Q2 2026.
Milestone Pharmaceuticals made up 0.01% of Beta Wealth Group's portfolio in Q2 2026, its #114 holding.
Beta Wealth Group first reported a position in Milestone Pharmaceuticals in Q4 2022 and has held it in 14 quarters since.
Beta Wealth Group's Milestone Pharmaceuticals position peaked at $55.9K in Q4 2022.
78 funds tracked by Wall St. Rank held Milestone Pharmaceuticals as of Q2 2026.

Based on Beta Wealth Group's 13F filing for Q2 2026, filed 24 Jul 2026.